340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...] …
Category: Federal
The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...] …
Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...] …
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...] …
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...] …
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] …
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...] …
Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...] …
The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...] …